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ABSTRACT
PORPHYROMONAS GINGIVALIS, ETHANOL, AND
CHRONIC DISEASES
Nicholas Alan Short
April 20, 2022
This dissertation is an investigation into the relationships among
Porphyromonas gingivalis, ethanol, and a series of chronic diseases, focusing
primarily on atherosclerosis. It uses evolutionary theory to understand clinical
parameters related to chronic disease biology. The initial research question was, "If
people who drink a glass of wine each day have a lower risk for atherosclerosis,
could one explanation involve antibacterial effects on pathogens associated with
causing atherosclerosis, namely, Porphyromonas gingivalis?".
This dissertation is divided into four chapters. Chapter One provides the
foundational information pertinent to the dissertation. Chapter Two describes an invitro experiment aimed at understanding how ethanol influences planktonic
Porphyromonas gingivalis. Chapter Three details an in-vitro experiment aimed at
learning how ethanol influences Porphyromonas gingivalis when it exists in a
biofilm. Chapter Four explores how Porphyromonas gingivalis and ethanol influence
rheumatoid arthritis, osteoporosis, Alzheimer's disease, chronic kidney disease, and
type II diabetes.
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Chapters Two and Three provide primary information resulting from
experiments that I designed and performed, while Chapter Four is more theoretical
in nature. The experiments detailed in Chapters Two and Three were designed to
understand how ethanol may differentially impact Porphyromonas gingivalis in the
bloodstream relative to the oral cavity.
The value of this dissertation lies in the synthesis of new ideas related to how
the most widely used drug (ethanol) can influence the leading cause of death
worldwide, heart disease. The use of ethanol as a systemic antimicrobial agent with
regards to chronic infectious diseases has generally been overlooked. The
hypothesis that ethanol consumption suppresses P. gingivalis growth in the blood,
but not the oral cavity, is supported by experiments and a review of the literature
presented in this dissertation.
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CHAPTER I
ATHEROSCLEROSIS, PERIODONTITIS, AND ETHANOL: PARADOXICAL RELATIONS
Introduction
Atherosclerosis is the leading cause of death worldwide, causing
approximately one-third of all human deaths globally [1]. It is a chronic disease
characterized by lipid depositions within arterial walls that progressively decrease
luminal diameter [2]. Atherosclerotic progression often results in ischemic or
hemorrhagic stroke or myocardial infarction [2]. According to the current paradigm,
atherosclerosis often begins prior to adulthood [3] and progresses throughout a
lifetime [4, 5].
Risk factors for atherosclerosis include smoking, elevated serum low-density
lipoprotein (LDL), decreased serum high-density lipoprotein (HDL), elevated serum
triglycerides, hypertension, obesity, and lack of exercise [6]. Evidence supports an
etiological role for bacterial pathogens in atherosclerosis [7, 8], though the results
are not consistent across studies or among patients within studies [9].
Moderate ethanol consumption has been implicated as protective against the
development of atherosclerosis, but the reasons for a protective effect are unclear
[10, 11] (Figure 1). This thesis will address the hypothesis that moderate alcohol
consumption could protect against atherosclerosis by inhibiting bacteria that may
contribute to atherosclerosis.
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Figure 1. Effect of ethanol on relative risk of coronary heart disease displays a Jshaped curve.
The curve favors low ethanol consumption for maximal benefits, while heavy
consumption increases risk of total mortality. The curve crosses RR=1.0 at
approximately 6-7 standard drinks/day. Adapted from [11].
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Cardiovascular System
The cardiovascular system includes the heart and blood vessels [12]. The
heart is a muscular organ that pumps blood throughout the body within a series of
blood vessels [12]. Blood travels away from the heart in arteries and returns to the
heart through veins [12]. Capillaries lie between arteries and veins and serve as a
site for exchange between blood and interstitial fluid of the tissues being served
[12].

Atherosclerosis Categorization and Diagnosis
Atherosclerosis is a cardiovascular disease characterized by plaque
accumulation within the walls of arteries [13]. Atherosclerosis diagnosis is
categorized according to the location of the diseased vasculature [14].
Atherosclerosis of the blood vessels serving the heart is referred to as coronary
artery disease [15]. Atherosclerosis of carotid arteries and other vessels supplying
blood to the brain is referred to as cerebrovascular disease. Atherosclerosis of blood
vessels in the upper and lower limbs is referred to as peripheral arterial disease [16,
17]. Each of these categories share an arterial pathology characterized by lipid
accumulation, decreased arterial elasticity, and decreased luminal diameter. For all
categories, major risks involve chronic ischemia or hemorrhage.
Physicians use a combination of laboratory tests and imaging techniques to
diagnose atherosclerosis risk and severity [18]. They detect the earliest stages of
atherosclerosis using non-invasive imaging techniques, measuring blood pressure,
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and performing blood tests. Blood samples from high-risk individuals display high
LDL, low HDL, high blood sugar, and elevated C-reactive protein [19].
Carotid intimal-medial thickness (c-IMT) is performed as a diagnostic
measure of clinical and subclinical atherosclerosis [20]. It is defined as the distance
from the luminal edge of the tunica intima to the outer edge of the tunica media
[21]. c-IMT increases as atherosclerosis progresses [20] and is associated with
increasing age [5]. The increased risk associated with age does not justify the
conclusion that atherosclerosis is a normal part of human senescence, as some [22]
claim. Rather, it may result from repeated or ongoing damage from the factors that
may contribute to atherosclerosis, such as infection.
Atherosclerotic plaques cause localized blood pressure changes due to
decreased luminal volume and decreased arterial elasticity. The ankle-brachial
pressure index (ABI) non-invasively compares blood pressure in the upper limbs
relative to lower limbs Peripheral arterial disease (PAD) diagnosis requires an ABI
value of 0.9 or less [23]. Low ABI suggests that blood pressure in the lower limbs
exceeds that from the upper limbs, and indicates lower limb atherosclerosis. The 0.9
value is used instead of 1.0 because the brachial artery is smaller than the femoral
artery and, therefore, experiences greater pressure in healthy individuals. ABI
values greater than one indicate that upper limb blood pressure exceeds lower-limb
blood pressure, and thus atherosclerosis in the upper limbs.

Porphyromonas gingivalis and Oral Biofilms
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Porphyromonas gingivalis (P. gingivalis) is a gram-negative bacterium that
contributes to periodontal disease when it proliferates in subgingival biofilms and
forms anaerobic pockets; damage to periodontal tissues results directly from
pathogen activity [24] and indirectly through immune responses [25]. P. gingivalis is
referred to as a keystone species because of its predominant impact on communities
of periodontal pathogens in biofilms where it is present in relatively low abundance
[26]. P. gingivalis uses two fimbriae, FimA and Mfa1, to adhere to other bacteria and
gingival epithelial cells[27]; P. gingivalis can invade human epithelial cells [24], a
process that involves FimA [28].
P. gingivalis relies on other organisms to colonize before it can become
incorporated into biofilms in vivo. Streptococcal species adhere to the acquired
pellicle on teeth, enabling additional organisms to attach to their surface proteins.
Streptococcus gordonii expresses membrane-bound proteins that facilitate P.
gingivalis adherence and biofilm integration [29]. Biofilms accumulate biomass as
they recruit bacteria into the microbial community and as adherent cells replicate
within the biofilm [30].
Bacteria that colonize biofilms are not necessarily permanently embedded
[31, 32]. Rather, they are able to leave the biofilm to allow transmission or to
colonize other sites [31, 32]. Although P. gingivalis is non-motile, it moves
throughout the oral cavity in saliva. P. gingivalis is transmitted from person to
person through when intimate relations and shared utensils allow spread via saliva
[33]. The ability to exit from biofilms therefore seems essential for its transmission.
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P. gingivalis can spread from oral biofilms by several routes. It can infect
lungs via aspiration and cause pneumonia [34]. It can invade gingival epithelial cells
[24] and spread intercellularly without entering the extracellular matrix [35]. This
attribute helps protect bacteria from the host’s immune system. Infected host cells
are killed by cytotoxic T cells, whereas extracellular infections are cleared without
the requirement of killing host tissue. Extracellular P. gingivalis can also gain entry
into the bloodstream by invading capillaries or damaged gingiva [36].
Periodontitis and Atherosclerosis
Gingival tissue serves as a physical barrier and protects teeth, maxillae, and
mandibulae from infection. Gingivitis and periodontitis exist on a spectrum,
whereby untreated gingivitis can progress to periodontitis [37]. Subgingival
bacteria cause periodontitis when they damage host tissue and promote chronic
inflammation. Tissue damage can result from microbial proteases and stimulation of
chronic inflammation [38]. Subgingival bacteria are embedded in a biofilm [39] that
helps them adhere to teeth. Biofilms contain living microorganisms and their
extracellular components within a matrix that attaches to a surface [29]. One of the
most important of these bacteria is P. gingivalis [39] [40] [41].
Periodontitis is a risk factor for atherosclerosis [42]. P. gingivalis is an
etiological agent of periodontitis and is thought to contribute to atherosclerosis [4345]. P. gingivalis spreads systemically when it penetrates capillary beds of breached
gingiva [7, 46]. It and several other periodontal pathogens (e.g., Trepomena
denticola, Tannerella forsythia, and Aggregatibacter actinomycetecomitans) have
been detected in atherosclerotic lesions excised from larger blood vessels, such as
6

coronary arteries [47, 48]. One group of researchers claims to have successfully
demonstrated that resected tissues contain viable P. gingivalis; although, the report
was a letter to the editor and not a peer-reviewed article [49].
It is thought that the oral pathogens travel from the oral cavity to the sites
where atherosclerosis develops via the bloodstream. Bacteria may gain entry to the
bloodstream by penetrating vascular tissue [24, 50, 51] or by travelling within
macrophages [52]. Poor oral hygiene is associated with increased risk of bacteremia
[53]. At the other extreme, people who brush and floss too roughly can damage
gingiva and cause bacteremia [54, 55].
Within an individual, the microbial compositions of subgingival and
atherosclerotic plaques are positively correlated [56]. Tissue from bypass surgeries
revealed that atherosclerotic and healthy arteries contain P. gingivalis, indicating
that infection may precede and potentially play a causal role in cholesterol
accumulation associated with atherosclerotic plaque synthesis rather than simply
being an opportunistic bystander that infects damaged arterial tissue [57].
When subgingival bacteria spread systemically they may infect arteries [57].
Oral pathogens are commonly detected in resected arterial tissue from individuals
who required surgical intervention for treatment of atherosclerosis [50, 57]. These
pathogens have not been viably cultured after resection [58], but their presence is
often recognized using polymerase chain reaction (PCR) [59] or fluorescent in-situ
hybridization (FISH) [45] to detect DNA or RNA. Pathogens may invade arteries
directly [60] or by traveling intracellularly within macrophages [61].
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Arterial walls increase in stiffness as atherosclerosis progresses, a process
that can be quantified before life-threatening cardiovascular complications arise.
Arterial stiffness is associated with decreased lipid concentration and increased
calcification [62]. Flow-mediated dilation is a measure of endothelial function that
quantifies how peripheral arteries dilate in response to increased blood flow
following artificial vasoconstriction using a sphygmomanometer cuff [63].
Individuals with periodontitis have higher c-IMT values and impaired flowmediated dilation when compared than those without periodontitis; both of these
values improve with periodontal treatment [64, 65]. This association provides a
correlation between oral pathogens and atherosclerosis development.
It is not known whether arterial tissue is a dead-end for colonizing pathogens
or if they are able to exit arteries and re-enter circulation. Arterial anatomy is such
that pathogens would have to invade multiple tissue layers to reach or exit the
tunica media, the region that typically accumulates cholesterol that contributes to
atherosclerosis. From the lumen, pathogens would have to pass through the tunica
intima, which contains an endothelial layer, the subendothelium, and an internal
elastic lamina. Alternatively, they could invade arteries via the vasa vasora, blood
vessels that extend superficially into deeper layers of large arteries and veins. While
all arteries and veins do not contain vasa vasora, they are present in the arteries
which atherosclerosis typically develops. These include the coronary arteries, aorta,
carotid arteries, brachial artery, iliac artery, and the femoral artery [66, 67].
As mentioned in the introduction, moderate ethanol consumption is
associated with a decreased risk for atherosclerosis [11]. The following sections will
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explore the effects of human ethanol consumption. Ethanol metabolism will be
reviewed, followed by a discussion of ethanol as an antimicrobial agent. These
contents will be applied to understanding how ethanol influences bacteria and
human tissue throughout the body and how these interactions influence an
individual's risk for developing chronic diseases.

Ethanol Metabolism and Pharmacokinetics
After ethanol is swallowed, it passes down the esophagus and enters the
stomach. Gastric tissue is about 400 micrometers thick, lending to poor diffusion
when compared to the small intestine, which is only about 25 micrometers thick
[68]. Gastric emptying into the small intestine is dramatically influenced by the
presence of food. Consumed ethanol reaches the small intestine much faster when
someone has not recently eaten; moreover, some of the ethanol is oxidized by the
bolus before emptying into the small intestine. Ethanol is primarily absorbed in the
small intestine into the capillaries of the hepatic portal system [69].
Once ethanol enters the liver via the portal vein, the deoxygenated blood
mixes with oxygenated blood from the hepatic artery within sinusoids. Ethanol will
be diluted within sinusoids, as roughly 1/3 of the blood serving the liver comes from
the hepatic artery. Hepatocytes catabolize ethanol, and what remains enters
systemic circulation via the hepatic vein. Ethanol is further diluted as the superior
and inferior vena cava mix blood from the upper and lower body.
Ethanol is typically metabolized at a rate of roughly ten grams per hour, but
some experience a blood alcohol concentration plateau for the first two hours
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following consumption [70]. Ethanol is primarily degraded in the liver, with only
about 5% of ingested amounts collectively remaining in urine, sweat, and breath
[71-75]. Blood alcohol concentration is usually highest about 30-60 minutes after
consumption [70, 76].
Chronic ethanol consumption can lead to increased ethanol tolerance,
suggesting that regular drinking patterns decrease ethanol’s effects and require
increased consumption to obtain effects that used to be reached with less
consumption [77, 78]. The National Institute of Health (1995) considers multiple
ways in which individuals can become tolerant as a result of chronic alcohol
consumption, including functional, acute, environment-dependent, learned,
environment-independent, and metabolic tolerance [78]. Tolerant individuals can
have a blood ethanol concentration of 0.1% and show no signs of intoxication;
whereas, those without tolerance would show visible signs of intoxication at this
concentration [77]. Highly tolerant individuals may reach blood ethanol
concentrations around 0.4-0.5%, even though such high levels could be lethal for
social drinkers [77].
Metabolic tolerance arises from increased efficiency at metabolizing ethanol
and can be considered a physiological adaptation to regular ethanol consumption
[79]. Alternatively, functional tolerance arises when the brain adapts to chronic
ethanol consumption to compensate ethanol’s physiological and behavioral effects
[79]. Individuals with functional tolerance can have elevated blood ethanol
concentrations while displaying no clear signs of intoxication, while the same
ethanol concentrations could be fatal for those without functional tolerance [80]. S.
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C. Lapham quotes a DUI offender who said, “Usually I was the designated driver
because my friends say I can drive better than anybody when I’m intoxicated… Five
beers is nothing to me” [77].
Blood alcohol concentrations in the hepatic portal system may be elevated
relative to concentrations in the rest of the bloodstream. Ethanol is degraded
primarily in the liver after leaving the hepatic portal system. Of the ethanol that
enters hepatocytes, roughly 75% of ethanol is catabolized to acetaldehyde by
alcohol dehydrogenase (ADH); the remaining 25% is catabolized to acetaldehyde
using cytochrome (CYP) P450 enzymes like CYP2E1. Catalase is a peroxisomal
enzyme to catabolize ethanol to acetaldehyde. Acetaldehyde is converted to acetate
by aldehyde dehydrogenase 2 (ALDH2), and this is the rate-limiting step that raises
concern regarding aldehyde reactivity.
Blood flows three times faster in the portal vein than the liver (0.75 and 0.25
liters/minute/kg, respectively) [81]. Bacteria in the portal vein blood can, therefore,
be exposed to ethanol at higher concentrations than elsewhere in the body for a
brief period of time [82]). This exposure may be important during first-pass
metabolism (FPM), which is defined as the amount of ethanol that is catabolized
prior to entering systemic circulation, aka “peripherally available (PA)”[81]. Simply
put, FPM= total oral dose – PA [83]. Although the contribution of first-pass
metabolism remains under debate, recent research suggests that only about 10% of
consumed ethanol is degraded in its first passage [84, 85].
Blood flows through the portal vein at a velocity of approximately 13
cm/second [86], and the portal vein is about 25 cm in length; therefore, ethanol
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traveling from the gastrointestinal tract to the liver would remain within the portal
vein for roughly two seconds before entering the liver [86-90]. This duration in
noteworthy because it is time that systemic bacteria would be exposed to the
highest possible blood alcohol concentration.

Ethanol as an Antimicrobial Agent
Ethanol is an aliphatic hydrocarbon with strong antimicrobial properties
[91-95]. The CDC (2008) recommends using 60-90% ethanol solutions in water
(volume/volume) to adequately kill microbes [95]. Ethanol damages microbes by
increasing membrane permeability and denaturing intracellular and extracellular
proteins, which explains why it is still commonly used in antimicrobial
mouthwashes [91-95]. Not all alcohols denature proteins, though. Glycerol is
commonly used to freeze microbial stock cultures at -80° C [94].
Bacterial species vary in their response to ethanol exposure. The CDC (2008)
refers to Morton’s 1950 publication, which claims that ethanol concentration
ranging within 30-100% killed Pseudomonas aeruginosa in ten seconds, and any
concentration within 40-100% ethanol killed Escherichia coli or Salmonella typhosa
in ten seconds [95, 96]. Staphylococcus aureus, a gram-positive bacterium, requires
60-95% ethanol to kill it within ten seconds [97].

Ethanol and Biofilms
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Ethanol (70%) is commonly used to disinfect catheters, as they have a
tendency to accumulate bacterial biofilms [98]. Recent findings demonstrate that
ethanol concentrations as low as 2.5% inhibit Pseudomonas aeruginosa biofilms
[98]. Other studies have shown that 1% ethanol stimulates P. aeruginosa biofilms
[99]. Polymicrobial biofilms display increased resistance to ethanol, as different
organisms have different capacities to withstand ethanol exposure [100, 101].
Understanding how ethanol influences microbial fitness becomes more complicated
when multiple species are involved, such as in oral biofilms.

Ethanol and Oral Microbiome
Ethanol consumption is positively associated with periodontitis risk [102].
Chronic ethanol consumption promotes a dysbiotic oral microbiome, increasing
one’s risk for periodontal disease [103-105]. Amaral et al (2011) demonstrated that
the subgingival microbiota in alcoholics was contained higher counts of pathogenic
bacteria than in non-alcoholics; although, the prevalence of bacterial species was
similar between groups [105]. Ethanol also directly damages gingival tissue and
decreases salivary secretions, both of which facilitate microbial pathogenesis [104,
106, 107]. Ethanol's effects extend beyond the oral cavity once someone swallows
and subsequently absorbs it into their bloodstream.

Ethanol and Cardiovascular Disease
One “standard drink” contains fourteen grams of ethanol [108]. Therefore,
for comparative purposes, the volume of a “standard drink” is inversely related to
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the concentration of ethanol in the beverage (i.e., lower volume for spirits and
higher volume for wine and beer). Because alcohol can damage human tissue, the
U.S. Department of Agriculture and U.S. National Institute of Health and Human
Services recommends that women consume no more that one drink per day and
men consume no more that two standard drinks per day [109].
Adults over twenty-one years of age are legally allowed to purchase and
consume ethanol in the United States. Underage drinking occurs frequently and
often results in binge drinking [110, 111]. Adolescent ethanol consumption is a
disease risk factor that tends to be more prevalent in boys than girls [112]. Results
from a 2015 survey of adolescents in the U.S. indicate that about 30% of fifteen
year-olds and 60% of eighteen year-olds have consumed at least one alcoholic drink
[110].
Health surveys [113] and meta-analyses [10] suggest that moderate ethanol
consumption reduces risk of cardiovascular disease-related morbidity and mortality
but that these ameliorating effects are lost when ethanol consumption continues
past a threshold amount. This dose/effect pattern is commonly referred to as a U- or
J-shaped curve [114]. If the negative effects of high alcohol consumption on
cardiovascular disease offset the beneficial effects associated with low alcohol
consumption the curve is U-shaped. If the negative effects of high alcohol
consumption are greater than the beneficial effects of low alcohol consumption,
then the curve is J-shaped [115] (Figure 1). The type of alcoholic beverage seems to
have little, if any, effect on this association, suggesting that major physiological
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effects are due to ethanol rather than other constituents, though, some research
supports a protective effect of resveratrol in wine (discussed below) [116, 117].
The protective effect of moderate ethanol consumption and the mechanisms
that could generate such protection are still being debated [118]. One possible
protective mechanism for ethanol-mediated protection from cardiovascular disease
could be through improvement of lipid profiles by increasing serum high-density
lipoprotein (HDL) and decreasing serum low-density lipoprotein (LDL) [119]. Low
to moderate alcohol consumption is associated with reduced inflammatory
biomarker concentration and improved glucose metabolism [120].
Meta-analyses suggest that moderate ethanol consumption decreases risk of
dying from a cardiovascular disease [116, 121]. Correlates of atherosclerosis
progression, however, do not necessarily show concordant associations. Carotid
artery intimal-medial thickness, for example, correlates with progression of
atherosclerosis. As discussed below, some analyses suggest that moderate ethanol
consumption promotes thickening of arterial walls [65, 122], while others generate
evidence of a J-shaped association between ethanol consumption and arterial wall
thickness [123].
Another uncertainty in this area of research involves ethical issues pertaining
to a researcher who has reported protective effects of moderate alcohol
consumption. The National Institute of Health and Human Services terminated
funding for a major prospective clinical trial that aimed to determine the health
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outcomes of moderate ethanol consumption when the principal investigator was
found to have a conflict of interest arising from his association with the alcoholic
beverage industry [124].
In spite of these uncertainties, the current state of research suggests that
moderate alcohol consumption provides protective effects. The lack of a clear
protective mechanism for such protection, however, may contribute to legitimate
reservations about the validity of the association. By testing a hypothetical
mechanism for this protection, the work described in this dissertation might be
useful to the evaluation of the validity of the hypothesized beneficial effects of
moderate alcohol consumption.

Experimental Animal Models Investigating the Effects of Ethanol Consumption
on Cardiovascular Disease Risk
Experimental investigations of animal models of cardiovascular disease have
provided evidence that bears on the effects of moderate alcohol consumption.
Removing the alcoholic fraction of a beverage allows researchers to compare the
effects of secondary compounds in the presence and absence of ethanol. An
experimental rabbit model was used to determine if ethanol or secondary
compounds found in dealcoholized red wine, such as resveratrol, conferred
cardiovascular protection [125]. The researchers found that red wine and
dealcoholized red wine provided similar increases in cardiovascular protection
when compared to controls that received neither beverage, suggesting that wine
components aside from ethanol provide cardiovascular protection [126].
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Apolipoprotein E-null mice (ApoE -/-) are commonly used as a model for
cardiovascular disease. These mice are unable to express apolipoprotein E, which
typically functions to bind to circulating serum lipoproteins and direct them to cellspecific receptors [127]. ApoE -/- mice are hypercholesterolemic and form arterial
lesions that resemble those found in humans [128]. These mice have been used to
experimentally investigate how daily moderate ethanol consumption or weekend
binging influenced atherosclerotic plaque development [129]. Compared with mice
that received no ethanol, daily ethanol consumers displayed less atherosclerotic
plaque and larger luminal diameters [129]. Mice provided with a binging dose of
ethanol had more plaques and smaller luminal diameters [129]. These results
suggest that moderate ethanol consumption is protective in mice, but heavy
consumption is harmful.

Following chapters
This dissertation aims to evaluate one aspect of a hypothetical mechanism by
which moderate alcohol intake could ameliorate atherosclerosis: though inhibition
of P. gingivalis. Chapter 2 addresses the extent to which different ethanol
concentrations inhibit P. gingivalis cultures that are in suspended in media rather
than in a biofilm. The suspended state is used as an indicator of effects of ethanol on
P. gingivalis that have left their biofilm microenvironment to move systemically
through the bloodstream. Chapter 3 addresses the extent to which different ethanol
concentrations inhibit P. gingivalis that are in a biofilm model, which is used as an
indicator of the effects of ethanol on P. gingivalis in the biofilm environment.
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Chapter 4 discusses the implications of the results for the spectrum of diseases that
are associated with P. gingivalis and for which correlations with alcohol intake have
been reported: periodontal disease, atherosclerosis, Alzheimer's disease, type 2
diabetes, and rheumatoid arthritis, as well as overall conclusions and directions for
future studies.
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CHAPTER II
EFFECTS OF ETHANOL ON PLANKTONIC PORPHYROMONAS GINGIVALIS

Introduction
This chapter reports experiments that investigated whether in vitro growth
of planktonic Porphyromonas gingivalis (i.e., suspended in media rather than in
biofilms) was inhibited by ethanol across a range of concentrations that include the
concentrations associated with low levels of alcohol ingestion. The goal is to
evaluate whether concentrations of ethanol over a range that might occur in the
bloodstream could inhibit P. gingivalis and thus reduce the risk for systemic
diseases caused by this pathogen.

Materials and Methods
General approach
Planktonic Porphyromonas gingivalis were exposed to a series of ethanol
concentrations in vitro over a twenty-four-hour period to allow most bacteria to
reach their stationary phase. To assess bacterial density, absorbance was measured
using spectrophotometry and colony-forming units were counted from growth on
agar plates. Absorbances provide precise measurements of a presumed indicator of
bacterial density, whereas the counts of colony-forming
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units allowed assessment of whether the absorbance in fact reflected the density of
viable bacteria.

Porphyromonas gingivalis
All experiments used Porphyromonas gingivalis wild-type (ATCC 33277)
obtained from Dr. Richard J. Lamont. Cultures were grown from frozen stocks and
maintained on blood agar plates. Trypticase Soy Broth (TSB, BD) was supplemented
with yeast extract (1 mg/mL), hemin (5 μg/mL), and menadione (1 μg/mL) to create
"TSB complete". Fresh blood agar plates containing TSB complete and sheep's blood
were prepared weekly for each experiment. The primary subculture was created by
inoculating TSB complete with isolated P. gingivalis colonies and pipetting to
resuspend the cells. The primary subculture (5.0 mL) was incubated anaerobically
at 37°C overnight. A secondary subculture was created the following morning by
combining 500 μL of primary subculture and 5.0 mL sterile TSB complete and
incubating anaerobically at 37°C overnight.
The secondary subculture was centrifuged at 3,000 RPM at 4°C for 10
minutes to create a pellet. The supernatant was aspirated using a Pasteur pipet, and
the resulting pellet was resuspended in 950 μL sterile TSB complete. Cells were
resuspended using gentle micropipetting. Optical density (O.D.) was measured using
an Eppendorf spectrophotometer at 600 nm.

Growth curves

20

Broth containing 0.001% to 10% molecular biology-grade ethanol was
prepared by performing ten-fold serial dilutions from a 10% ethanol broth created
with 4.5 mL sterile TSB complete and 0.5 mL ethanol. These ethanol concentrations
were chosen to encompass blood ethanol concentrations occurring after
consumption of feasible ranges of ingested ethanol. A blood ethanol concentration of
approximately 0.001% would be expected during the slow consumption of a
standard drink. The drunk driving limit of 0.08% blood ethanol conforms roughly to
the experimental concentration of 0.1% ethanol. The 1% and 10% ethanol
concentrations was used as negative controls under in recognition that these levels
of ethanol was far outside of the range of blood ethanol concentrations associated
with moderate ethanol consumption [130]. Absorbances and colony counts for each
ethanol concentration were compared statistically with positive controls (P.
gingivalis in 0% ethanol).
All samples initially contained 5.0 mL sterile TSB complete in 15.0 mL
centrifuge tubes and were inoculated with 5 x 108 cells (O.D.= 0.1). Each preparation
was performed in duplicate, and each duplicate was replicated independently six
times. Caps were loosened prior to anaerobic incubation. Data were collected in the
form of optical density measurements and colony-forming units at baseline, 30
minutes, 4 hours, 6 hours, 12 hours, 18 hours, and 24 hours. Optical density
measurements used 500 μL from each sample after homogenization using
micropipetting.
Bacterial concentrations at each time point were determined using a
modified spread plate method, in which each plate contained twelve samples (four
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sets of triplicates) for quantifying colony forming units (CFUs). Each plate was
divided into four quadrants to save materials, and triplicate 20 μL volumes from
each experimental sample were diluted to either 1/10,000 or 1/1,000,000, plated,
and spread into each quadrant using a pipette tip. Dilutions were chosen based on
results from prior experiments, depending on how many colonies were expected to
grow. Triplicate samples were used to verify CFU counts due to the variability
associated with small volumes. Samples were incubated anaerobically on blood-agar
plates containing TSB complete for seven days to allow colonies to grow and display
black pigmentation, a visual indication of colony maturation. Averages were
calculated from the triplicated counts, and colony-forming units (CFUs) per mL were
calculated using the appropriate dilution factor from the day the sample was plated.
P. gingivalis growth rates were calculated using the following formula: µ =
((log10 N - log10 N0) 2.303) / (t - t0) [131]. Optical density values were multiplied by
109 before performing growth rate calculations. The initial time point was at 6
hours, and the final time point was at 12 hours, corresponding to the two points
encompassing logarithmic growth. The data are presented in Table 1.

Statistical analysis
Two-way ANOVA tests were performed to compare bacterial density under
experimental and control conditions. Absorbances were compared with the
corresponding measurements for controls. Statistical tests were performed on the
data at four and six hours because these time intervals corresponded to the time
period in which P. gingivlalis cells replicates; statistical tests were run at 24 hours to
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determine whether the ethanol concentrations inhibited growth at a time when the
density in the positive control samples had reached stationary phase. Statistical
analyses were performed using R. The threshold for ascribing statistical significance
was p=0.05.
Results
Ethanol inhibits planktonic Porphyromonas gingivalis growth.
Measurements of absorbance as a function of time show that 10% ethanol
was associated with a steady decline in absorbance (Figure 2), indicating that this
level of ethanol killed P. gingivalis. Absorbance increased over the 24-hour
experimental period for ethanol concentrations of 1.0%, 0.1%, 0.01%, 0.001%, and
0% ethanol (Figure 2). These increases indicate that P. gingivalis was able to survive
and replicate under these ethanol concentrations. The absorbance curves appeared
to rise more slowly, however, with increasing ethanol concentration (Figure 2). This
hypothesis was tested for statistical significance as discussed below.
Under the conditions used in this study, P. gingivalis replicates roughly every
four to five hours [24] [132]. The approximate doubling of absorbance at four hours
relative to zero hours (Figure 2) is consistent with this replication rate. The
absorbance curve for 0% ethanol rose and then flattened sigmoidally during the 24hour experimental period with an inflection point between 6 and 12 hours (Figure
2). The leveling off of absorbance by 18 hours (Figure 2) indicates some inhibition of
bacterial growth by this time, probably due to depletion of the resources needed for
bacterial growth. This feedback inhibition associated with bacterial growth is also

23

apparent in the absorbance curves for each ethanol concentration ranging from
0.001% to 1.0%.
In accordance with these considerations, assessments of the ethanol
inhibition at four and six hours were used as the best indicators of ethanol
inhibition that is not confounded by the inhibitory effects of resource depletion.
Statistical tests to evaluate ethanol therefore focused on differences in the
absorbances at 4 and 6 hours (Figure 3). Each experimental ethanol concentrations
ranging from 0.001% to 0.1% significantly inhibited planktonic bacteria after four
hours and six hours of ethanol exposure relative to the 0% controls (Figure 3).
Overall, the results presented in Figures 1 and 2 suggest that ethanol
concentrations from 0.001% to 1% ethanol inhibited but did not prevent replication
of P. gingivalis; 10% ethanol, however, prevented growth.
At 24 hours of exposure, absorbances for ethanol concentrations at 0.001%,
0.01% and 0.1% were not significantly lower than absorbances associated with 0%
ethanol (Figure 4). This lack of difference suggests that these concentrations slowed
growth to the equilibrium but still allowed the bacteria to grow to the equilibrium
value. This finding accords with the hypothesis that the equilibrium at these
concentrations is constrained by the resources in the media rather than by ethanol
inhibition.
The CFUs recorded from inoculated agar plates confirmed that absorbance
readings reflected viable P. gingivalis (Figure 2b). For ethanol concentrations from
0.001% to 0.1% CFUs increased and then leveled off over the 24-hour experimental
period with a pattern that accorded with the changes in absorbance (Figures 2b and
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2a, respectively). For P. gingivalis exposed to 10% ethanol, CFUs declined steadily
over this period, indicating that ethanol at this level prevented bacterial
proliferation and eventually killed the bacteria.
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a.

b.
Figure 2. Planktonic P. gingivalis growth curves.
(a.) Absorbance of P. gingivalis in liquid growth media with different ethanol
concentrations as functions time exposed to ethanol (hours after inoculation). Each
data point is based on 12 measurements: six independent experimental replicates
with 2 measurements per replicate for each time and each concentration. (b.)
Samples were plated each time that an optical density measurement was obtained.
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Ethanol Concentration (%)
0
0.001
0.01
0.1
1
10

Average Growth Rate (μ)
0.264236559
0.281291402
0.280184977
0.274182489
0.259925377
-0.114344069

Standard Deviation
0.045858639
0.046835392
0.049862388
0.046838472
0.106589981
0.129258963

Table 1: P. gingivalis mid-logarithmic growth rates.
P. gingivalis growth rates were calculated using the following formula: µ = ((log10 N log10 N0) 2.303) / (t - t0) [131].
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Figure 3. Absorbance of P. gingivalis in liquid growth media with different ethanol
concentrations at four and six hours after inoculation.
Each riser in the histogram corresponds to a data point in Figure 2. Asterisks
designate statistically significant differences from the absorbances associated with
the 0% ethanol controls at each time period. * p<0.05 , ** p<0.01
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Figure 4. Absorbance of P. gingivalis in growth media with different ethanol
concentrations at twenty-four hours after inoculation.
Each riser in the histogram corresponds to a data point in Figure 2. Asterisks
designate statistically significant differences from the absorbances relative to the
0% ethanol controls at each time period. * p<0.05, ** p<0.01
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Discussion
The results show that physiologically relevant ethanol concentrations (i.e.,
0.01%-0.1%) inhibit planktonic growth of P. gingivalis. This finding is consistent
with the hypothesis that low blood ethanol concentrations could inhibit P. gingivalis
bacteremia and, thus, protect against atherosclerosis. Although the inhibitory effects
of physiologically relevant ethanol concentrations were slight, they might contribute
to protection against P. gingivalis by tipping the balance in favor of immunological
control.
The lack of conspicuous systemic P. gingivalis infections in humans suggests
that the immune system is broadly able to suppress systemic P. gingivalis infections
[133-135]. This suppression apparently occurs even though periodontal bacteria
frequently enter the bloodstream as a result of activities such as eating, brushing
teeth, and flossing [55, 136]. Presumably, frequent pathogen exposure allows for
relatively continuous mobilization of immunological defenses against them [134,
135]. Transient bacteremia typically contains about 10-100 bacteria per mL blood
and is resolved in about an hour (reviewed by [134]).
Higher concentrations of ethanol increasingly inhibited P. gingivalis. Humans
presumably have evolved immune systems that function well at levels of ethanol
that were regularly present during our evolutionary history from fermented foods
and symbiotic microbiota [137]. Accordingly, negative effects of ethanol on immune
function may occur at higher concentrations but not at concentrations associated
with low levels of ethanol consumption [138]. The net effect of ethanol on control of
candidate causal pathogens may thus become negative at higher ethanol intake
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because the negative effects on the immunological function outweighs the direct
negative effect of the ethanol on the pathogens.
Physiologically relevant ethanol concentrations span a range because
pathogens are exposed to different ethanol concentrations depending on the
amount of ethanol ingested, the time since ingestion and their location in the body.
The oral cavity and esophagus experience the highest ethanol concentrations.
Absorption occurs slightly in the stomach but mostly in the small intestine. Plasma
ethanol concentrations decline as ingested ethanol in the blood travels throughout
the body as a result of degradation and dilution. The portal vein transports blood
from the gastrointestinal tract to the liver where substantial degradation of ethanol
occurs. The liver receives approximately 25% of cardiac output at rest, with twothirds coming from the portal vein and one-third from the hepatic artery [90, 139].
Upon leaving the liver, blood that arrived from the portal vein is mixed with blood
from the hepatic artery.
Calculations based on enzyme kinetics indicate that ethanol concentrations
in the portal vein are roughly ten times higher than in the blood leaving the liver
[140]. P. gingivalis in systemic circulation may therefore often be subjected to
ethanol concentrations in the portal vein that are far higher than the blood
concentrations that are measured in blood draws or breaths. Someone who drank a
sip or two of a diluted beverage would have approximately 0.001% of their total
blood volume as ethanol. A standard drink would result in 0.02-0.04% blood
ethanol, similar to the 0.01% experimental condition. The drunk driving limit in
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most states is 0.08% blood ethanol, similar to the experimental concentration of
0.1% ethanol.
One caveat for interpretation of these experimental results is that exposure
to the ethanol concentrations used in the experiments were continuous, whereas,
exposure in vivo would vary depending on the aforementioned factors. My results
leave open the question of whether alcohol in the oral cavity inhibits P. gingivalis or
other organisms that might contribute to cardiovascular disease. Although the levels
of ethanol in the oral cavity could be high, P. gingivalis in the oral cavity is most
often embedded with other organisms in biofilms [29, 141]. Biofilm formation might
protect bacteria from the damaging effects of ethanol, a possibility that needs to be
investigated experimentally. This hypothesis is addressed in the next chapter.
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CHAPTER III
EFFECTS OF ETHANOL ON PORPHYROMONAS GINGIVALIS IN A BIOFILM MODEL
Introduction
Biofilms contain living microorganisms and their extracellular components
within a matrix that attaches to a surface [29]. Biofilms may benefit microbes by
allowing them to adhere to a substrate, stimulate nutrient secretion [39], facilitate
metabolically mutualistic relationships with other microbes [142], and allow
organisms to evade host defenses [143]. In the case of oral biofilms, microorganisms
adhere to teeth [144]. Oral biofilms can contain approximately 700 microbial
species, about half above and half below the gumline [145]. Anaerobic pathogens in
oral biofilms persist in subgingival pockets where they can avoid oxygen exposure
and access nutrients from gingival crevicular fluid [39], a serum-based exudate fluid
that contains inflammatory cells and antimicrobial biochemicals [146].
This chapter reports an experimental investigation of whether the range of
ethanol concentrations reported in Chapter 2 adversely affect P. gingivalis when it is
present in an in vitro biofilm model. This work addresses a paradox arising from the
association between ethanol consumption and risks of periodontitis relative to
atherosclerosis. Specifically, in contrast with the J-shaped association of
atherosclerosis with ethanol consumption, periodontal disease increases linearly
with increases in ethanol consumption [10, 113, 147].
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If atherosclerosis and periodontitis are both caused by the same periodontal
pathogens [43], then why does ethanol consumption influence the disease risk
profiles so differently? The findings reported in Chapter 2 suggest that moderate
ethanol consumption may inhibit planktonic P. gingivalis. The inhibitory influence
on pathogens may occur without compromising immune responses [148],
generating a net protective effect against reducing the probability infections of
vascular tissue [50]. If P. gingivalis biofilms protect it from exposure to ethanol, then
moderate ethanol consumption may fail to inhibit P. gingivalis in the oral cavity
sufficiently to generate protection from periodontal disease.
The experiment reported in Chapter 2 showed that moderate concentrations
of ethanol inhibited planktonic P. gingivalis growth and viability. This chapter
reports a complementary experiment that investigated whether the same ethanol
concentrations had inhibitory effects on P. gingivalis in an in vitro biofilm model.

Materials and Methods
Culturing of Porphyromonas gingivalis from stock
All experiments used Porphyromonas gingivalis wild-type (ATCC 33277)
obtained from Dr. Richard J. Lamont. Cultures were grown from frozen stocks and
maintained on blood agar plates. Trypticase Soy Broth (TSB, BD) was supplemented
with yeast extract (1 mg/mL), hemin (5 μg/mL), and menadione (1 μg/mL) to create
"TSB complete". Fresh blood agar plates containing TSB complete and sheep's blood
were prepared weekly for each experiment. The primary subculture was created by
inoculating TSB complete with isolated P. gingivalis colonies and pipetting to
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resuspend the cells. The primary P. gingivalis subculture (5.0 mL) was incubated
anaerobically at 37°C overnight. A secondary subculture was created the following
morning by combining 500 μL of primary subculture and 5.0 mL sterile TSB
complete and incubating anaerobically at 37°C overnight.
The secondary subculture was centrifuged at 3,000 RPM at 4°C for 10
minutes to create a pellet. The supernatant was aspirated using a Pasteur pipet, and
the resulting pellet was resuspended in 950 μL sterile 0.5x TSB complete (TSB
complete diluted into sterile phosphate buffered saline, PBS). Cells were
resuspended using gentle micropipetting. Optical density (O.D.) was measured using
an Eppendorf spectrophotometer at 600 nm.

Experimental design optimization
Prior to conducting the experiments, P. gingivalis biofilm development was
optimized by measuring the extent to which biofilms grow in response to either (1)
buffer (1x PBS) or broth (0.5x TSB complete), (2) high (5 x 108 cells/mL) or low (2 x
107 cells/mL) inoculum concentration, (3) time exposed to ethanol (0, 0.5, 1, or 4
hours), and (4) concentration of ethanol exposure (0.001% - 50%). Data are
presented in Figure 5. Experiments were performed using 96-well plates that
contained either 1x PBS or 0.5 x TSB complete. Different 96-well plates were used to
expose biofilms to ethanol for various amounts of time (0, 0.5, 1, or 4 hours). The
lower inoculation concentration was used on the left side of the 96-well plates, and
the higher inoculation concentration was used on the right side of the 96-well
plates. The full spectrum of ethanol concentrations was included in each 96-well
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plate. Taken together, one complete set of data required eight different 96-well
plates. All experimental conditions were run in triplicate. Biofilm growth was
measured via spectrophotometry at 595 nm using the crystal violet staining
technique [149]. Results from these experiments (n=6) were used to design
subsequent biofilm experiments (see below).

Biofilm experiment
Four 24-well plates were used for each replicated experiment. One "set" of
plates includes two 24-well plates in order to accommodate all experimental
conditions. One set of plates was used to determine the biofilm density at 24 hours,
and the other set of plates was used to determine the biofilm density at 48 hours.
One mL of P. gingivalis subculture (2 x 107 cells/mL) in 0.5x TSB complete
was inoculated into each experimental well of four 24-well plates. Control wells
received only sterile medium (0.5x TSB complete). All four plates were incubated
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Figure 5: Optimization of P. gingivalis Biofilms (n=6).
Biofilms were grown overnight in either 1x PBS or 0.5x TSB complete, treated with
ethanol, stained using crystal violet, and the absorbance was measured at 595 nm.
Asterisks designate significant differences between absorbances for each ethanol
concentration at relative to the broth control. Results from this set of experiments
were used to optimize the conditions for subsequent experiments, which used 2 x
107 P. gingivalis cells/mL in 0.5x TSB complete. ANOVAs were performed the cutoff
for statistical significance at p<0.05 (*).
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anaerobically on a 3D rocker for 24 hours hours. Following overnight incubation,
the supernatants were discarded, leaving P. gingivalis in a biofilm at the bottom of
each experimental well [150]. The remaining biofilms were then treated with one of
several concentrations of ethanol (0%, 0.01%, 0.1%, 1.0% or 10%) diluted into 0.5x
TSB complete and incubated anaerobically for four hours with 3D rocking. The fourhour ethanol exposure time was chosen based on results from the experiments
contained in Chapter 2 and preliminary data collected while optimizing the
experiments contained within this chapter. Experimental wells were created using
the same 10-fold serial dilutions used in the experiments described in Chapter 2, but
this experiment used 0.5x TSB complete instead of 1x TSB complete.
Following the four-hour ethanol treatment, one set of plates was washed,
stained with crystal violet, and the absorbance at 595 nm was measured. The other
set was rinsed with 1x PBS and provided with sterile TSB complete for an additional
18-hour incubation period. Following overnight 3D rocking, the remaining biofilms
were washed with 1x PBS and stained with crystal violet. Absorbances were
measured at 595 nm to assess whether the P. gingivalis remaining in the biofilm
after the various four-hour ethanol treatments were viable. Viable biofilms should
increase in biomass between 24 hours and 48 hours when provided with fresh
medium, while dead biofilms should not increase in biomass when provided fresh
medium. This experiment was performed three times (n=3), and the data were
averaged for further analysis.

Statistical analysis
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The data were normalized by subtracting the broth control from the
experimental values. Two-way ANOVA was performed in R across ethanol
concentrations at 24 and 48 hours to determine if growth was significantly different.
Statistical tests were performed on the resulting data. A p-value of 0.05 was used as
the threshold for statistical significance.
Results
Physiological concentrations of ethanol do not inhibit P. gingivalis in biofilms
Absorbances of P. gingivalis after 24 hours of biofilm development were
similar across ethanol concentrations from 0% to 1% (Figure 6). The absorbances
associated with each ethanol concentration from 0.001% to 1.0% were not
significantly different from the absorbance associated with 0% ethanol (P>0.05 for
each comparison; Figure 6). These results indicate that P. gingivalis under the
biofilm conditions were not adversely affected by four hours of exposure to ethanol
concentrations ranging from 0.001% to 1.0%.
Absorbances after 48 hours of incubation (an additional 24 hours of after the
four hours of ethanol exposure) were significantly greater than absorbances at 24
hours for ethanol concentrations from 0% to 1% (Figure 6). This difference
indicates that P. gingivalis in the biofilm environment not only survived four hours
of ethanol exposure at concentrations up 0.001 to 1%, but it also replicated at these
concentrations over the 48-hour study period (Figure 7, red bars). The consistently
lower absorbances associated with 10% ethanol indicate that this concentration
killed P. gingivalis in biofilms (Figure 7).
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Figure 6: P. gingivalis live/dead biofilms (n=3).
Optical densities were measured after 4 hours ethanol treatment using a plate
reader at 24- and 48-hours of biofilm development. Asterisks designate significant
differences between absorbances for each ethanol concentration at 48 hours
relative to 24 hours. ANOVA was performed the cutoff for statistical significance at
p<0.01 (**).
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Discussion
The results suggest that biofilms offer protection against ethanol exposure.
In the planktonic experiments reported in Chapter 2, concentrations of ethanol
ranging from 0.001% to 1.0% inhibited P. gingivalis after four hours of ethanol
exposure. The experiment reported in this chapter indicates that, under biofilm
conditions, these concentrations did not inhibit P. gingivalis after four hours of
exposure.
Unlike larger molecules, ethanol can cross plasma membranes and penetrate
biofilm [98, 151]. It therefore would be reasonable to hypothesize that ethanol could
negatively affect P. gingivalis in biofilms. The results of this experiment indicate,
however, that the in vitro biofilm does afford protection against the low-tomoderate ethanol concentrations that adversely affect planktonic P. gingivalis.
Several large-scale clinical trials and meta-analyses suggest that ethanol
consumption increases risk for periodontal disease linearly with no protection
associated with low levels of consumption [102, 147]. This association contrasts
with the J-shaped curve that characterizes ethanol consumption and atherosclerosis
risk. This difference would seem to negate the idea that moderate ethanol
consumption reduces atherosclerosis risk by inhibiting P. gingivalis. The results of
the experiments in Chapters 2 and 3, however, provide the basis for an alternative
hypothesis: moderate ethanol consumption may protect against atherosclerosis by
inhibiting planktonic P. gingivalis but may fail to protect against periodontal disease
because the biofilm in which P. gingivalis is embedded protects against the
antimicrobial effects of ethanol. In the absence of a protective antimicrobial effect,
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even low levels of ethanol consumption may exacerbate periodontal disease. The
increased damage from periodontal disease with increasing ethanol consumption
presumably occurs because host defenses are increasingly compromised.
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CHAPTER IV
CHRONIC DISEASES ASSOCIATED WITH PORPHYROMONAS GINGIVALIS

Introduction
Porphyromonas gingivalis is positively associated with several chronic
diseases in addition to atherosclerosis: rheumatoid arthritis, osteoporosis,
Alzheimer's disease, chronic kidney disease, and type 2 diabetes. If P. gingivalis
contributes causally to any of these diseases as a result of systemic planktonic
spread, the logic presented in this thesis suggests that moderate alcohol
consumption might also be associated with protection. In this chapter, I discuss the
evidence from the biomedical literature pertaining to associations of these chronic
diseases with periodontal disease, P. gingivalis, and ethanol consumption. I use the Jshaped association between ethanol consumption and atherosclerosis presented in
Chapter 1 as a benchmark for comparison. Specifically, this chapter assesses
whether low-to-moderate ethanol consumption is associated with protection and
high ethanol consumption is associated with exacerbation of each chronic disease,
taking into account disease-specific pathologies (Figure 7).
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Figure 7. Contributions of P. gingivalis and ethanol to chronic diseases throughout
the human body.
P. gingivalis invades host tissues throughout the body. The left panel provides
mechanisms regarding P. gingivalis-mediated pathology, and the right panel
describes how ethanol influences each chronic disease.
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Rheumatoid Arthritis
P. gingivalis is thought to contribute to rheumatoid arthritis when it
stimulates an autoimmune response in joints [152]. P. gingivalis produces
gingipains, which cleave proteins at specific amino acid residues [153]. P. gingivalis
then citrullinates cleaved proteins using peptidyl arginine deiminase (PPAD)
[152].The immune system produces anti-citrullinated protein antibodies (ACPAs) in
response to the citrullinated proteins [152]. Citrullinated proteins and the ACPAs
are hallmarks of rheumatoid arthritis [152].
A meta-analysis found that people who consume ethanol were less likely to
develop rheumatoid arthritis [154]. One hypothesis for this association is that
ethanol suppresses immune function. Ethanol exposure may interfere with T cell
function, dysregulating communication between T cells and B cells that would lead
to antibody responses to extracellular infections [155]. Additionally, ethanol
interferes with antigen presentation and cytokine production [156].
The general argument presented in this thesis provides an alternative
hypothesis for the ameliorative effect of ethanol on rheumatoid arthritis by invoking
inhibition of planktonic P. gingivalis. Rheumatoid arthritis is negative associated
with amount of ethanol consumed rather than having a J-shaped association [154].
That is, even high levels of ethanol consumption are associated with amelioration of
rheumatoid arthritis. Because rheumatoid arthritis is an autoimmune disease,
ameliorative effects at all levels of ethanol consumption is consistent with both
antimicrobial and immunosuppressive effects of ethanol occurring jointly: ethanol
could be ameliorating rheumatoid arthritis in part by inhibiting P. gingivalis but the
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inhibitory effects of ethanol on immune function could be ameliorating rather than
exacerbating the immunopathology.

Osteoporosis
Osteoporosis is a disease characterized by decreased bone density, which
typically occurs during the later decades of life, but it can occur earlier in association
with calcium deficiency, use of certain pharmaceuticals, or chronic infection.
Additional risk factors include cigarette smoking, sedentary lifestyle, and high
alcohol consumption (more than seven standard drinks per week) [157].
Periodontitis is one infectious risk factor, as the causal pathogens are well known to
stimulate bone resorption [158]. P. gingivalis may induce bone resorption when its
LPS activates TLR-2 on osteoblasts, promoting periosteal osteoclast maturation that
leads to pathogenic bone loss [159].
Experiments performed on rats demonstrated that periodontal disease
contributes to increased severity of osteoporosis [158]. Researchers induced
periodontitis using a ligature model over an eight-week period, while control rats
did not receive ligation wires. The animals were sacrificed after eight weeks, and the
fourth vertebra, the femur, the tibia, periodontal tissues, and blood were analyzed
for evidence of osteoporosis, periodontal disease, or systemic pathogens,
respectively. The researchers performed PCR on the periodontal silk and blood
samples to look for nine periodontal pathogens. ELISA was used to quantify tumor
necrosis factor alpha, interleukin 6, bone glutamic acid protein, and type 1 collagen
C-terminal peptide (CTX-1). Bone resorption was measured using micro-computer
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tomography. Bone histopathology was performed by staining tissues with
hematoxylin-eosin (H & E) and tartate-resistant acid phosphatase.
Rats in the PD group displayed more bone resorption than controls. Staining
revealed bone-resorbing osteoclasts in the PD group but not in the control group.
Pro-inflammatory cytokines and CTX-1 were significantly more elevated in rats with
PD than in control rats. Rats in the PD group also displayed more bone resorption
and more osteoclasts than WT controls. Porphyromonas gingivalis was one of
several pathogens detected in blood samples and from silk ligatures from sacrificed
mice with experimentally induced PD [158]. Taken together, this study provides
evidence for the association of P. gingivalis infection and subsequent bone loss in
vivo.
Studies suggest that low ethanol consumption may improve bone mineral
density, while heavy ethanol consumption decreases bone mineral density [160].
Different types of alcoholic beverages seem to affect bone physiology differently;
distilled liquor is more damaging than beer or wine [160], perhaps because distilled
liquor can be associated with higher ethanol levels. The effects of moderate ethanol
consumption seem to depend largely on age, sex, and lifestyle. For example,
moderate alcohol may increase bone density in men and postmenopausal women
but not in premenopausal women [161]. Ethanol may not increase bone density in
premenopausal women because they have elevated antibody responses relative to
postmenopausal women [162 {Fish, 2008 #6599, 163]. A reliance on humoral
immunity in premenopausal women is one hypothesis to explain this association if
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planktonic bacteria are controlled sufficiently well by antibodies in the absence of
ethanol.

Alzheimer's Disease
Olsen and Singhrao reviewed potential mechanisms by which P. gingivalis
can contribute to Alzheimer's disease [164]. Gingipains damage tau proteins and
contribute to tangle formation [165], a hallmark of Alzheimer's disease. If damaged
tau proteins are a contributing cause of Alzheimer's disease rather than a side effect,
then this damage may be a mechanism by which P. gingivalis contributes to
Alzheimer's disease. Gingipains appear to enhance growth of P. gingivalis in the
brain. Small-molecule inhibitors of gingipains, termed Kgps, reduce the bacterial
load in the brain and prevent some neuronal damage [165].
Plaques of amyloid beta in the brain are another hallmark of Alzheimer's
disease [166]. Amyloid beta has antimicrobial effects against P. gingivalis [165].
Higher levels of amyloid beta in the brains of people with Alzheimer's disease may
be a response to P. gingivalis in neuronal tissue; increased beta amyloid might itself
then cause neuronal damage and/or be a side effect of damage caused by P.
gingivalis. Elevated levels of amyloid beta seem to be associated with a reduction in
living bacteria, most likely due to the effects of amyloid beta on membrane integrity
[165].
Light to moderate ethanol consumption appears to reduce risk of developing
Alzheimer's disease, particularly in people who do not carry the ApoE4 allele [167].
Heavy ethanol consumption, together with positivity for the ApoE4 allele, increase
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risk of developing Alzheimer's disease [167]. These results accord with the
hypothesis that planktonic P. gingivalis plays a role in sporadic Alzheimer's disease
and that moderate ethanol intake confers some protection.

Chronic Kidney Disease
Chronic kidney disease is diagnosed either by finding renal damage or by
measuring a decline in filtration over three months. People with periodontal disease
have an increased risk for developing chronic kidney disease [168, 169]. An
association between subgingival periodontal pathogen detection and severity of
kidney disease suggests that systemic infections play a role the development or
exacerbation of renal disease [168, 170]. Some researchers report that elevated
antibody production against P. gingivalis is associated with reduced kidney function
[170, 171], although one study found an inverse relationship between antibodies
against periodontal pathogens and chronic kidney disease [172].
Periodontal disease is associated with renal insufficiency, defined as a
glomerular filtration rates less than 60 mL/min/1.73 m2 [173].
One possible pathogenic mechanism could involve infection of the glomerulus or
renal artery. A recent review (2019) suggests that P. gingivalis contributes to
atherosclerotic clot formations in renal vasculature; by this mechanism
periodontitis contributes to atherosclerosis, and atherosclerosis causes chronic
kidney disease [174]. Pathological outcomes involve occluded vasculature and blood
clot formation, both of which decrease renal perfusion.
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Ethanol consumption has a J-shaped risk profile relative to chronic kidney
disease; lower consumption reduces risk and high consumption increases risk
relative to nondrinkers [175, 176]. If P. gingivalis plays a role in chronic kidney
disease, then ethanol may protect the kidneys from infection until the point at which
heavy concentrations of ethanol generate renal damage that outweighs any
beneficial effect of inhibiting P. gingivalis.

Type 2 Diabetes
Periodontitis risk and severity is elevated in type 1 [177] and type 2 diabetics
[178]. Diabetes diagnosis requires evidence of chronic hyperglycemia, typically
involving glycated hemoglobin, fasting plasma glucose, random glucose tests, or an
oral glucose tolerance test [179].
Experimental approaches demonstrate the multifactorial nature of insulin
resistance, as evidenced by dietary, genetic, and infectious contributions. High-fat
[180] and high-sugar diets [181] exacerbate insulin resistance [180] and alveolar
bone loss [181, 182] in periodontitis-diabetes comorbid mice. Moreover, mice with
experimentally induced periodontitis and diabetes develop atherosclerotic lesions
that contain Porphyromonas gingivalis [181]. Systemic P. gingivalis infects the liver
and is able to invade hepatic cells, where it may alter glucose uptake or metabolism
[183].
Porphyromonas gingivalis contributes to insulin resistance by inhibiting
insulin receptor substrate 1 (IRS1), Akt, and glycogen synthase kinase-3 beta (GSK3B) phosphorylation, each of which are involved in the response to the binding of
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insulin to its receptor [183]. Disrupted insulin signal transduction leaves diabetics
unable to import and store blood glucose levels because cells fail to appropriately
translocate GLUT 4 transporters to the cell's surface and the liver fails to synthesize
glycogen [183].
Although P. gingivalis has been thought to be unable to use glucose, the
emerging sense is that it uses glucose facultatively depending on
microenvironmental conditions [184]; moreover, chronic hyperglycemia may favor
species in the oral microbiome that may, in turn, favor P. gingivalis. Saccharolytic
streptococcal species colonize sugar-protein dental pellicles and provide "landing
zones" for incoming microbiota. Streptococcus gordonii binds with the major and
minor fimbriae of P. gingivalis and thus fosters the ability of P. gingivalis to persist in
biofilms [132, 185]. These findings emphasize the importance of considering
relationships between diabetes and microbial species that interact with P. gingivalis
in the oral microbiome when assessing the possibility that ethanol could ameliorate
the negative effects of diabetes.
GLUT 2 transports glucose bidirectionally across the intestines, kidneys,
liver, and pancreas. Hyperglycemia induces gut permeability and systemic microbial
dissemination. Glucose enters intestinal cells via GLUT2 from the intestinal lumen
and from systemic circulation; intracellular protein glycosylation then leads to
chronic inflammation [186]. Enzymes glycosylate proteins and lipids, whereas
glycation occurs non-enzymatically in blood by chance interactions.
Irreversible Advanced Glycation End products (AGEs) result when proteins
or lipids are exposed to glucose, resulting in glycation [187]. AGEs are used as a
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diagnostic marker for type 2 diabetics because chronic hyperglycemia results in
protein or lipid glycation. Considerations of the interplay between periodontitis and
the AGEs implicate contributions of periodontitis to diabetes and hence the
potential for amelioration of diabetes through inhibition periodontal pathogens
(e.g., through ethanol consumption). Diabetics with severe periodontitis accumulate
more AGEs than diabetics with less advanced periodontitis, suggesting that
periodontal pathogens may promote AGE formation [178].
Glycated proteins and lipids fail to function properly and may eventually
become pro-inflammatory AGEs [187]. AGEs are recognized by the AGE receptor
(RAGE), which stimulates the NF-kB inflammatory pathway when activated. AGEs
may thus contribute to inflammation-associated pathology of diabetes. Oral AGEs
may also enhance the success of P. gingivalis in biofilms by providing non-dental
colonization sites for streptococci such as S. gondonii..
Treatment of periodontitis provides additional evidence that periodontal
pathogens contribute to type 2 diabetes. Treating periodontitis with systemic
antibiotics reduces probing depth, subgingival Porphyromonas gingivalis
colonization, and serum glycated hemoglobin [188].
A 2016 compilation of fourteen meta-analyses [189] provides a large body of
evidence that periodontal treatment reduces circulating levels of glycated
hemoglobin. Only one study [190] found HbA1c reductions in response to treatment
of periodontal disease that exceeded one percent. Such reductions are associated
with improved vascular health and lower risk of mortality caused by diabetes or
myocardial infarction [189]. This analysis suggests that periodontal pathogens
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contribute to the chronic hyperglycemia conditions that promote HbA1c formation,
and removing pathogens from the oral cavity reduces this process.
A meta-analysis including nearly two million subjects suggests that moderate
ethanol consumption reduces risk of developing type 2 diabetes [191]. The peak risk
reduction was reached at about one standard drink per day, and the risk of
developing type 2 diabetes increased after about five standard drinks per day [191].
Consumption of one standard drink per day reduced diabetes risk by 18% relative
to nondrinkers. This finding is consistent with the J-shaped relationship between
ethanol consumption and atherosclerosis.

Overview of Ethanol and Chronic Diseases associated with P. gingivalis
This chapter assessed whether chronic diseases that are associated with P.
gingivalis are ameliorated in people who consume ethanol. For each of the five
chronic diseases characterized by pathology outside of the oral cavity, low-tomoderate ethanol consumption was associated with protection. These findings
contrast with the progressively increasing exacerbation of periodontal disease that
is associated with increased ethanol consumption. These findings accord with the
idea that ethanol has inhibitory effects on P. gingivalis when it is planktonic
(Chapter 2) but not when it is embedded in its periodontal biofilms (Chapter 3). For
five of these chronic diseases-- atherosclerosis, chronic kidney disease, Alzheimer's
disease, osteoporosis and type 2 diabetes—evidence implicates a J-shaped curve:
amelioration associated with moderate ethanol consumption but exacerbation for
high ethanol consumption. In contrast, rheumatoid arthritis appears to be
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ameliorated across the spectrum of ethanol consumption. This difference could be
related to the tendency for rheumatoid arthritis to be an autoimmune disease, with
the inhibition of P. gingivalis by high levels of ethanol consumption being
supplemented by suppression of an autoimmune pathology.
If ethanol ameliorates these chronic diseases outside the oral cavity by
suppressing P. gingivalis, it could do so directly by reducing the ability of P.
gingivalis to cause tissue damage that leads to the diseases; for example, P. gingivalis
could contribute to chronic kidney disease by damaging the glomerulus. However,
comorbidities of these diseases raise the possibility that effects could be indirect; for
example, P. gingivalis could cause atherosclerosis of the renal artery that could, in
turn, damage kidney function. Chronic infections may take decades to diagnose, and
bacteremia can lead to infections throughout various organs. Therefore, it may
useful to determine the sequence of chronic disease development; for example,
periodontitis may cause atherosclerotic plaque of the renal artery, which in turn
may chronic kidney disease as a result of hypoperfusion through the renal artery
[174].
A related point is that ethanol may suppress the early development of
particular chronic diseases. Future studies could consider, for example, how the
combination of ethanol and P. gingivalis influences foam cell formation, an aspect of
the early pathogenesis of atherosclerosis. P. gingivalis can induce foam cell
formation, and moderate ethanol consumption is associated with reduced risk of
atherosclerosis,; however, the influence of ethanol on foam cell formation has not
been investigated.
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The elevated blood glucose associated with type 2 diabetes may result in
increased oral biofilm formation which in turn could generate more planktonic P.
gingivalis which could cause an upward spiral in glucose levels and diabetes severity
if unchecked by ethanol. The elevated glucose might also exacerbate other systemic
infections that play a role in these chronic diseases (e.g., C. pneumoniae in
atherosclerosis and Alzheimer's disease or Hepatitis C in type 2 diabetes).

Concluding Remarks
It is evident that the association between oral and systemic disease requires
a great deal of attention moving forward. Elucidating disease etiology facilitates
treatment and prevention strategies. P. gingivalis can infect a variety of human
tissues, some of which may require specialized drugs depending on where the
infection localizes. For example, a systemic antibiotic may be useful for bacteremia
but do nothing to treat a brain infection. Small molecule inhibitors are one strategy
that can be utilized without generating antibiotic resistance. Public health measures
to maintain oral hygiene may also be a helpful strategy.
Regarding how ethanol consumption affects chronic disease biology,
moderate amounts of ethanol may protect the consumer if the ethanol negatively
impacts infectious agents more than it damages the host. It seems counter-intuitive
that a poison would reduce risk for developing a chronic disease until one considers
the etiological events that produce disease. Ethanol travels systemically, but it
becomes diluted as it is absorbed into the bloodstream. These diluted volumes of
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ethanol may be elevated enough to curb pathogenicity but low enough to avoid
damaging host tissues.
Studies concerning the ability of P. gingivalis to evolve ethanol tolerance
could also be valuable. Oral pathogens may adapt to increasingly elevated ethanol
concentrations over decades of alcohol use, and such organisms could pose a
greater risk to systemic dissemination if they evolve tolerance mechanisms.
The value of this dissertation lies in the synthesis of new ideas related to how
the most widely used drug (ethanol) may influence the leading cause of death
worldwide, heart disease, as well as other chronic diseases. The use of ethanol as a
systemic antimicrobial agent with regards to chronic infectious diseases has
generally been overlooked. The hypothesis that ethanol consumption suppresses P.
gingivalis growth in the blood, but not the oral cavity, is supported by experiments
and review of the literature presented in this dissertation.
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